Free Trial
NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

iShares U.S. Pharmaceuticals ETF logo
$68.76 -0.53 (-0.76%)
(As of 12:15 PM ET)

About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Key Stats

Today's Range
$68.57
$69.38
50-Day Range
$68.34
$72.20
52-Week Range
$57.11
$72.94
Volume
7,453 shs
Average Volume
59,313 shs
Market Capitalization
$694.48 million
Assets Under Management
$623.50 million
Dividend Yield
5.42%
Net Expense Ratio
0.40%
Aggregate Rating
Moderate Buy

ETF Overview

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.40%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.30%0.49%0.58%0.53%
Total Expense0.40%0.70%0.71%0.73%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%
Net Expense0.40%0.61%0.61%0.58%0.59%
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

IHE ETF News Headlines

Healthcare ETFs tumble as UnitedHealth stock weighs
Trump’s Back, but DC’s Coming for Your Money!
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…
SEC Approves Spot Ether ETFs
See More Headlines

IHE ETF - Frequently Asked Questions

iShares U.S. Pharmaceuticals ETF's stock was trading at $61.80 at the beginning of 2024. Since then, IHE stock has increased by 12.1% and is now trading at $69.26.
View the best growth stocks for 2024 here
.

iShares U.S. Pharmaceuticals ETF shares split on the morning of Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly issued shares were issued to shareholders after the closing bell on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

iShares U.S. Pharmaceuticals ETF's top institutional shareholders include Fisher Asset Management LLC (33.19%), Raymond James & Associates (0.47%), Southern Capital Advisors LLC (0.40%) and Thrivent Financial for Lutherans (0.32%).

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Adobe (ADBE), Lam Research (LRCX) and Advanced Micro Devices (AMD).

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
42

Fund Statistics

Assets Under Management
$623.50 million
Average Daily Volume
$42,219.20
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
N/A
Short Interest
98,300 shs

Miscellaneous

Beta
0.58
Creation Unit
50,000
Creation Fee
$306.00
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Top 10 IHE Holdings

IHE Sector Exposure

IHE Industry Exposure


This page (NYSEARCA:IHE) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners